Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Dual Therapy of Dexamethasone and Palonosetron and Triple Therapy of Dexamethasone, Palonosetron, Fosaprepitant for Postoperative Nausea and Vomiting Prevention: a Randomized Controlled Trial

NCT05773950 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT05773950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05773950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Dual Therapy of Dexamethasone and Palonosetron and Triple Therapy of Dexamethasone, Palonosetron, Fosaprepitant for Postoperative Nausea and Vomiting Prevention: a Randomized Controlled Trial
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
August 18, 2023
Completion date
December 31, 2025
Enrollment
144 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gynecologic surgical procedures, laparoscopy, postoperative nausea and vomiting